Chemical Compound
Arfolitixorin; L-Glutamic acid, N-[4-[(6aR)-3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-; Glutamic acid, N-[p-(3-amino-5,6,6a,7-tetrahydro-1-hydroxyimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-, L-(+)- (8CI); L-Glutamic acid, N-[4-(3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-, (R)-; N-[4-[(6aR)-3-Amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-L-glutamic acid; (6R)-5,10-Methylene-5,6,7,8-tetrahydrofolic acid; (6R)-5,10-Methylenetetrahydrofolate; 5,10-Methylene-(6R)-tetrahydrofolic acid; Arfolitixorin; L-(+)-Methylenetetrahydrofolic acid; d-N5,N10-Methylene-L-tetrahydrofolic acid; (2S)-2-[4-[(6aR)-3-Amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzamido]pentanedioic acid; (6aR)-5,10-Methylenetetrahydrofolic acid
CAS Registry Number
31690-11-6
Primary record
Arfolitixorin; L-Glutamic acid, N-[4-[(6aR)-3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-; Glutamic acid, N-[p-(3-amino-5,6,6a,7-tetrahydro-1-hydroxyimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-, L-(+)- (8CI); L-Glutamic acid, N-[4-(3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-, (R)-; N-[4-[(6aR)-3-Amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-L-glutamic acid; (6R)-5,10-Methylene-5,6,7,8-tetrahydrofolic acid; (6R)-5,10-Methylenetetrahydrofolate; 5,10-Methylene-(6R)-tetrahydrofolic acid; Arfolitixorin; L-(+)-Methylenetetrahydrofolic acid; d-N5,N10-Methylene-L-tetrahydrofolic acid; (2S)-2-[4-[(6aR)-3-Amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzamido]pentanedioic acid; (6aR)-5,10-Methylenetetrahydrofolic acid
- 库存
- 2,552 克
- 纯度
- 99.4 %
- CAS
- 31690-11-6
化合物标识与属性
- CAS
- 31690-11-6
- PubChem CID
- 135398645
- SMILES
- C1[C@@H]2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- Canonical SMILES
- Nc1nc2c(c(=O)[nH]1)N1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)C[C@H]1CN2
名称与同义词
- Arfolitixorin
- Modufolin
- Arfolitixorina
- Arfolitixorine
- arfolitixorinum
- Arfolitixorin [USAN]
- CH2H4folate
- 6R-MTHF
- 6R-methylene THF
- arfolitixorin sulfate
- (6R)-5,10-Methylenetetrahydrofolate
- 5,10-methylene-THF
- 31690-11-6
- ARFOLITIXORIN [INN]
- AC1L9HGC
- 5,10-methylenetetrahydrofolate
- RefChem:559928
- UNII-Z8R4A37V9Q
- Z8R4A37V9Q
- 6R-5,10-methyleneTHF
- Levofolinate EP Impurity I
- Arfolitixorin (USAN/INN)
- ARFOLITIXORIN [WHO-DD]
- ISO-901
- Methylenetetrahydrofolic acid, L-(+)-
- Arfolitixorin (Technical Grade)
- L-(+)-methylenetetrahydrofolic acid
- SCHEMBL186747
- DTXSID60185584
- CHEBI:1989
- orb1701177
- SCHEMBL4109116
- 5,10-Methylenetetrahydrofolic acid
- Calcium Levofolinate EP Impurity I
- (6R)-5,10-methylenetetrahydrofolic acid
- CHEMBL1234270
- SCHEMBL29616436
- ANX-510
- DTXCID00108075
- QYNUQALWYRSVHF-OLZOCXBDSA-N
- 6R-5-10-Methylenetetrahydrofolate
- 5,10-methylene-(6r)-tetrahydrofolic acid
- 5,10-Methylene-6-Hydrofolic Acid
- BCP09003
- ZINC4228243
- (6R)-5,10-MTHF
- CID445117
- MSK177032
- WHO 10689
- (6R) 5,10-methylenetetrahydrofolate
- [6R] 5,10-methylenetetrahydrofolate
- AKOS040747841
- (6R)-5,10-methylene-tetrahydrofolate
- [6R]-5,10-methylene-tetrahydrofolate
- DB12676
- FM171168
- (6R,S)5,10-methylene-tetrahydrofolic acid
- 5,10-methylene,5,6,7,8-tetrahydrofolate
- J540.096A
- 5,10-METHENYL-6,7,8-TRIHYDROFOLIC ACID
- CS-0031556
- NS00069867
- D-N5,N10-METHYLENE-L-TETRAHYDROFOLIC ACID
- N5,N10-Methylene-5,6,7,8-tetrahydrofolate
- A12370
- D11447
- (6R)-5,10-METHYLENE-5,6,7,8-TETRAHYDROFOLIC ACID
- Q26995704
- (2S)-2-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid
- (6r,s)-5,10-methylene-5,6,7,8-tetrahydrofolic acid
- (6R)-5,10-methylenetetrahydrofolate ((6R)-5,10-MTHF)
- [6R]-5,10-methylenetetrahydrofolate ([6R]-5,10- MTHF)
- [6R]-5,10-methylenetetrahydrofolate ([6R]-5,10-MTHF)
- (2S)-2-[[4-[(6aR)-3-amino-1-oxo-4,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid
- (S)-2-(4-((R)-3-Amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1H,4H,9H)-yl)benzamido)pentanedioic acid
- 3432-99-3
- L-GLUTAMIC ACID, N-(4-((6AR)-3-AMINO-1,2,5,6,6A,7-HEXAHYDRO-1-OXOIMIDAZO(1,5-F)PTERIDIN-8(9H)-YL)BENZOYL)-
- N-({4-[(6ar)-3-Amino-1-Oxo-1,2,5,6,6a,7-Hexahydroimidazo[1,5-F]pteridin-8(9h)-Yl]phenyl}carbonyl)-L-Glutamic Acid
- N-{4-[(6aR)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl}-L-glutamic acid
- (2S)-2-((4-((6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo(1,5-f)pteridin-8-yl)benzoyl)amino)pentanedioic acid
- (2S)-2-((4-((6aR)-3-amino-1-oxo-5,6,6a,7,8,9-hexahydro-2H-imidazo(1,5-f)pteridin-8-ium-8-yl)benzoyl)amino)-5-hydroxy-5-oxopentanoate
- (2S)-2-((4-((6aR)-3-amino-1-oxo-5,6,6a,7,9,10-hexahydro-2H-imidazo(1,5-f)pteridin-10-ium-8-yl)benzoyl)amino)-5-hydroxy-5-oxopentanoate
- (2S)-2-({4-[(6aR)-3-amino-1-oxo-1H,2H,5H,6H,6aH,7H,8H,9H-imidazo[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid
- (2S)-2-[[4-[(6aR)-3-amino-1-oxo-5,6,6a,7,8,9-hexahydro-2H-imidazo[1,5-f]pteridin-8-ium-8-yl]benzoyl]amino]-5-hydroxy-5-oxopentanoate
- (2S)-2-[[4-[(6aR)-3-amino-1-oxo-5,6,6a,7,9,10-hexahydro-2H-imidazo[1,5-f]pteridin-10-ium-8-yl]benzoyl]amino]-5-hydroxy-5-oxopentanoate
- (S)-2-(4-((R)-3-Amino-1-oxo-5,6,6a,7-tetrahydro imidazo[1,5-f]pteridin-8(1H,4H,9H)-yl)benzamido)pentanedioic acid
- (S)-2-(4-((R)-3-Amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1H,4H,9H)-yl)benzamido)pentanedioicacid
- Arfolitixorin; L-Glutamic acid, N-[4-[(6aR)-3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-; Glutamic acid, N-[p-(3-amino-5,6,6a,7-tetrahydro-1-hydroxyimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-, L-(+)- (8CI); L-Glutamic acid, N-[4-(3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-, (R)-; N-[4-[(6aR)-3-Amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-L-glutamic acid; (6R)-5,10-Methylene-5,6,7,8-tetrahydrofolic acid; (6R)-5,10-Methylenetetrahydrofolate; 5,10-Methylene-(6R)-tetrahydrofolic acid; Arfolitixorin; L-(+)-Methylenetetrahydrofolic acid; d-N5,N10-Methylene-L-tetrahydrofolic acid; (2S)-2-[4-[(6aR)-3-Amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzamido]pentanedioic acid; (6aR)-5,10-Methylenetetrahydrofolic acid
- MeF
- MHF
- N-({4-[(6aR)-3-amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]phenyl}carbonyl)-L-glutamic acid
- N-(4-((6AR)-3-AMINO-1-OXO-1,2,5,6,6A,7-HEXAHYDROIMIDAZO(1,5-F)PTERIDIN-8(9H)- YL)BENZOYL)-L-GLUTAMIC ACID
- N-[4-(1,2,5,6,6abeta,7,8,9-Octahydro-1-oxo-3-aminoimidazo[1,5-f]pteridine-8-yl)benzoyl]-L-glutamic acid
- N-[4-[(6aR)-3-Amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-L-glutamic acid; (6R)-5,10-Methylene-5,6,7,8-tetrahydrofolic acid; (6R)-5,10-Methylenetetrahydrofolate; 5,10-Methylene-(6R)-tetrahydrofolic acid; L-(+)-Methylenetetrahydrofolic acid; d-N5,N10-Methylene-L-tetrahydrofolic acid;
- N-[4-[[(6aR)-1-Oxo-3-amino-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridine]-8(9H)-yl]benzoyl]-L-glutamic acid
- N-[4-[[(6aR)-3-Amino-1,2,5,6,6abeta,7,8,9-octahydro-1-oxoimidazo[1,5-f]pteridin]-8-yl]benzoyl]-L-glutamic acid
- N-{4-[(6aR)-3-Amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl}-L-glutamic acid
- TMF